DR. JAMES WALTER RYAN, M.D.
Osteopathic Medicine at Lake Forest Dr, Augusta, GA
License number
Georgia 40532
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Georgia 40532
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
3047 Lake Forest Dr, Augusta, GA 30909
Phone
(706) 737-8670
Personal information
See more information about JAMES WALTER RYAN at radaris.comName
Address
Phone
5269 Riverview Rd, Atlanta, GA 30327
480 Ballyshannon Dr, Dacula, GA 30019
Professional information
Isolated Genomic Polynucleotide Fragments From Chromosome 12 That Encode Human Carboxypeptidase M And The Human Mouse Double Minute 2 Homolog
US Patent:
7754424, Jul 13, 2010
Filed:
Jun 27, 2003
Appl. No.:
10/608463
Inventors:
James W. Ryan - Augusta GA, US
International Classification:
C12Q 1/68, C07H 21/02
US Classification:
435 6, 536 231
Abstract:
The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Isolated Genomic Polynucleotide Fragments From The P15 Region Of Isolated Genomic Polynucleotide Fragments From The P15 Region Of Chromosome 11 Encoding Human Tumor Suppressing Subtransferable Candidate 4 (Tssc4)
US Patent:
8476417, Jul 2, 2013
Filed:
Sep 24, 2011
Appl. No.:
13/244468
Inventors:
James Ryan - Augusta GA, US
International Classification:
C07H 21/02, C07H 21/04, C12Q 1/68, C12P 19/34, C12N 5/00, C12N 5/02
US Classification:
536 231, 536 243, 536 2433, 536 245, 435 6, 435 911, 435325, 435375
Abstract:
Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human and tumor suppressing subtransferable candidate 4 (TSSC4) and methods of use.
Identification Of Isolated Genomic Nucleotide Fragments From The P15 Region Of Chromosome 11 Encoding Human Tumor Suppressing Subtransferable Candidate 4 (Tssc4) And Variants Thereof
US Patent:
2013018, Jul 25, 2013
Filed:
Mar 18, 2013
Appl. No.:
13/846050
Inventors:
RYOGEN LLC - Suffern NY, US
James Ryan - Augusta GA, US
James Ryan - Augusta GA, US
Assignee:
RYOGEN LLC - Suffern NY
International Classification:
C12Q 1/68
US Classification:
435 611, 435 612
Abstract:
Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human and tumor suppressing subtransferable candidate 4 (TSSC4) and methods of use.
Isolated Genomic Polynucleotide Fragments That Encode Human Lipoprotein-Associated Phospholipase A2
US Patent:
8241849, Aug 14, 2012
Filed:
Nov 25, 2008
Appl. No.:
12/323364
Inventors:
James W Ryan - Augusta GA, US
Assignee:
Ryogen LLC - Suffern NY
International Classification:
C12Q 1/68, C12Q 1/00, C12N 9/20, C12N 15/00, C12N 1/20, C12P 21/04, C12P 19/34, C07H 21/04, C07H 21/02
US Classification:
435 61, 435198, 4352523, 4353201, 435 691, 435 711, 435 911, 435440, 435 4, 536 232, 536 231
Abstract:
The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Isolated Genomic Polynucleotide Fragments From The P15 Region Of Chromosome 11
US Patent:
8039602, Oct 18, 2011
Filed:
Oct 31, 2001
Appl. No.:
09/999121
Inventors:
James W. Ryan - Augusta GA, US
Assignee:
Ryogen LLC - Suffern NY
International Classification:
C07H 21/02, C07H 21/04, C12Q 1/68, C12P 19/34, C12N 5/00
US Classification:
536 231, 536 243, 536 2433, 536 245, 435 6, 435 911, 435325, 435375
Abstract:
The invention is directed to isolated genomic polynucleotide fragments from the p15 arm of chromosome 11.
Isolated Genomic Polynucleotide Fragments That Encode Human Lipoprotein-Associated Phospholipase A2
US Patent:
7468266, Dec 23, 2008
Filed:
May 30, 2002
Appl. No.:
10/161127
Inventors:
James W. Ryan - Augusta GA, US
Assignee:
Ryogen, LLC - Suffern NY
International Classification:
C12N 9/20, C12N 15/00, C12N 1/20, C12Q 1/68, C12Q 1/00, C12P 21/04, C07H 21/04
US Classification:
435198, 435 4, 435 6, 435 691, 435 711, 435 911, 4352523, 4353201, 435440, 536 232, 536 231
Abstract:
The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Identification Of Isolated Genomic Nucleotide Fragments From The P15 Region Of Chromosome 11 Encoding Human Ribosomal Protein L26 (Ribo26) And Variants Thereof
US Patent:
2013018, Jul 25, 2013
Filed:
Mar 18, 2013
Appl. No.:
13/845838
Inventors:
RYOGEN LLC - Suffern NY, US
James Ryan - Augusta GA, US
James Ryan - Augusta GA, US
Assignee:
RYOGEN LLC - Suffern NY
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26) and methods of use.
Identification Of Human Mouse Double Minute 2 Homolog Nucleotide Sequences
US Patent:
2013007, Mar 21, 2013
Filed:
Nov 19, 2012
Appl. No.:
13/680247
Inventors:
RYOGEN LLC - Suffern NY, US
James Ryan - Augusta GA, US
James Ryan - Augusta GA, US
Assignee:
RYOGEN LLC - Suffern NY
International Classification:
C12Q 1/68
US Classification:
435 611, 435 612
Abstract:
The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Isolated Genomic Nucleic Acid Molecules Obtainable From Chromosome 1P21-P13 That Encode Human Rhoc
US Patent:
8053195, Nov 8, 2011
Filed:
Oct 10, 2003
Appl. No.:
10/683016
Inventors:
James W. Ryan - Augusta GA, US
International Classification:
C07H 21/02, G01N 33/53, C12P 21/04, C12N 15/00
US Classification:
435 71, 536 231, 435 6, 435 41, 435 711, 4353201, 506 3, 506 9, 506 16, 424 111
Abstract:
The invention is directed to an isolated genomic nucleic acid molecule fragment that encodes human RhoC, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human RhoC and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Isolated Genomic Polynucleotide Fragments From Chromosome 12 That Encode Human Carboxypeptidase M
US Patent:
8338100, Dec 25, 2012
Filed:
Sep 24, 2011
Appl. No.:
13/244474
Inventors:
James Ryan - Augusta GA, US
Assignee:
Ryogen LLC - Suffern NY
International Classification:
C12Q 1/68, C07H 21/02
US Classification:
435 612, 536 231
Abstract:
The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.